➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Baxter
Dow
Boehringer Ingelheim
Medtronic

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

AMINOSYN-PF 7% Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Aminosyn-pf 7%, and when can generic versions of Aminosyn-pf 7% launch?

Aminosyn-pf 7% is a drug marketed by Icu Medical Inc and is included in one NDA.

The generic ingredient in AMINOSYN-PF 7% is amino acids. There are three hundred and fifty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.

US ANDA Litigation and Generic Entry Outlook for Aminosyn-pf 7%

A generic version of AMINOSYN-PF 7% was approved as amino acids by B BRAUN on April 13th, 2012.

  Start Trial

Summary for AMINOSYN-PF 7%
Drug patent expirations by year for AMINOSYN-PF 7%
Pharmacology for AMINOSYN-PF 7%
Drug ClassAmino Acid

US Patents and Regulatory Information for AMINOSYN-PF 7%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc AMINOSYN-PF 7% amino acids INJECTABLE;INJECTION 019398-001 Sep 6, 1985 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Express Scripts
Merck
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.